StonvexLoading…
StonvexStonvexStonvexCore line items from KALU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.11B | $3.37B | $2.44B | $1.60B |
Operating Income | $97.80M | $188.80M | $128.20M | $79.40M |
Net Income | $62.50M | $112.50M | $84.30M | $23.20M |
EPS (Diluted) | $3.71 | $6.77 | $5.10 | $2.72 |
Total Assets | $2.79B | $2.56B | $2.59B | $2.51B |
Total Liabilities | $1.91B | $1.74B | $1.79B | $1.74B |
Cash & Equivalents | $30.00M | $7.00M | $17.20M | $13.10M |
Free Cash Flow OCF − CapEx | $68.50M | $-25.50M | $25.60M | $-8.90M |
Shares Outstanding | 16.34M | 16.21M | 16.21M | 16.18M |